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Laboratory tests are often requested without a clear indication of 
potential benefit or cost implications.1-4 Previous studies have shown 
that various interventions can reduce the number of tests ordered and 
thereby reduce the costs associated with hospitalisation.5
The Department of Internal Medicine at the University of Pretoria 
conducted a survey in 2007 to assess the level of ignorance regarding 
the cost of diagnostic laboratory tests among registrars in the 
department. This survey was done because the laboratory budget 
was grossly overspent for the year 2006. The survey, purely part 
of an internal audit and not intended for publication of any kind, 
demonstrated an 84% failure rate and confirmed the assumption 
that physicians’ estimates of laboratory costs, as has been the case 
in many other studies, were off by 45 - 75%.6 In a recent Medline 
and Cochrane review, it was emphasised that doctors have a limited 
knowledge and understanding of diagnostic costs. More focus in 
educating them in this regard is required, and these costs should be 
made accessible to them.7
Most diagnostic and therapeutic services are ordered by physicians 
on behalf of patients – traditionally under fee-for-service conditions 
such as in the South African public sector. These physicians as 
a rule do not need to make cost-containment a major factor in 
their decision process.8 In fact, there is ample evidence of over-
utilisation of such services, and it remains unclear who should pay for 
unnecessary medical services – the patient, the doctor, the hospital or 
the state coffer.9,10 It has been proposed that physicians should share 
the financial responsibility for over-utilisation of services that they 
have ordered or provided.
Factors contributing to excessive use of laboratory tests in teaching 
hospitals may be divided arbitrarily according to institutional, 
physician, laboratory and patient factors.11,12 Potential systems to 
identify responsibility for over-utilisation of medical services have 
been identified and include auditing in various forms, providing 
information on costs, obtaining second opinions, and incentives to 
improve cost containment.13
We investigated whether physicians would order fewer diagnostic 
tests after having been given the cost of laboratory tests during the 
test-ordering process.
Objectives and methodology
We aimed to ascertain the efficacy of an intervention in which 
laboratory test costs were provided to clinicians as a pocket-sized 
brochure in reducing laboratory test costs over a 4-month period, 
compared with a control group and with a control period in the 
preceding year. The study was approved by the Ethics Committee of 
the Faculty of Human Health Sciences of the University of Pretoria.
This was a non-randomised intervention study where the 
intervention group was compared with a similar and concurrent 
control group regarding the difference in laboratory test costs 
over a specified period in a specific year. The costs incurred were 
also computed for the same two groups over an identical time and 
seasonal period in the preceding year, referred to as the control 
period.
The study was conducted in the Internal Medicine wards at Steve 
Biko Academic Hospital, Gauteng province, South Africa. The 
intervention period was May - August 2008, and the pre-intervention 
period was the same months of the preceding year.
Physicians in the intervention group were supplied with an A5 
Z-flyer providing information on all laboratory costs typically 
ordered by the Department of Internal Medicine. They were asked 
to write in the cost of every test ordered on the laboratory test 
request form, specially labelled in the intervention group but not in 
the control group. A weekly audit of all these labelled request forms 
over the entire intervention period ensured 100% compliance by the 
physicians in the intervention group in entering the cost of the tests. 
Physicians in another Internal Medicine unit were not aware of this 
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information and continued to order tests as they would normally 
do. Care was taken that doctors did not change units or exchange 
information in the intervention period. More specifically, both 
groups worked independently during the specified period and the 
control group physicians were completely blinded to the intervention 
in progress. The physicians working in both groups were matched in 
terms of experience – specifically with regard to level of study and 
number of years after qualification.
Because the study had been planned in advance, it was possible 
to allow the same physicians to work in the same units in the year 
preceding the intervention and over the same time period. Hence 
it became possible to compute the cost of laboratory tests in both 
groups in the pre-intervention period (the control period) and during 
the intervention period.
The groups were compared using t-tests for transformed data 
and Mann-Whitney tests if skewed. As anticipated, the cost data 
were skewed and were normalised by logarithmic transformation 
(requiring the use of geometric means in the descriptive analysis). 
The differences in the log costs (logarithmic transformed costs) per 
day were compared over time using ANOVA (analysis of variance) 
with group, time and group*time as factors. To provide a clearer 
interpretation of the differences in geometric means over time 
between the groups, we calculated the 95% confidence interval for 
the ratio of geometric means of period 1 versus period 2 for the two 
groups, as indicated in Table I.
Results
In the two 4-month periods (2007 and 2008), for each patient 
admitted, the number of days in hospital and the laboratory tests 
ordered were computed from the ward register and the National 
Health Laboratory Service (NHLS) computer, respectively. In 
addition, pre- and post-intervention cost and days in hospital were 
estimated for both the intervention group and the control group. The 
cost difference between the two periods was compared between the 
two groups.
According to Table II, the baseline demographics were similar 
in the two groups, both in the pre-intervention period and in the 
intervention period, with no statistical differences. Table II shows 
that the mean cost per patient admitted in the intervention group 
decreased from R2 864.09 to R2 097.47 as a result of the intervention 
– a 27% reduction. The mean cost per day in the intervention group 
as a whole also decreased, from R442.90 to R 284.14, due to the 
intervention – a 36% reduction. These reductions in costs were 
incurred despite the expected annual increase in laboratory test costs 
of 2.5%. In contrast, in the control group all costs increased from 
the pre-intervention to the intervention periods, the mean cost per 
Table II. Patient demographics
Intervention Control p-value
Pre-intervention (2007) N= 260 N=203
Mean age (yrs) 51.31 51.12 0.91
Gender
(male/female (%)) 148 (57%)/112 (43%) 90 (44%)/113 (56%) 0.09
Intervention (2008) N=217 N=217
Mean age (yrs) 52.43 50.67 0.19
Gender
(male/female (%)) 105 (48%)/112 (52%) 96 (49%)/121 (51%) 0.75
Table I. Hospitalisation and cost data
Intervention group Control group p-value
Pre-intervention (2007) N=260 N=203
Days   in hospital (median (min - max)) 7 (1 - 47) 6 (1 - 34) 0.18 
Cost per day in hospital (R) (GMean (range))
442.90
(403.33 - 486.36)
363.54 
(322.98 - 409.19) 0.09
Cost per admission (R) (GMean (range))
2 864.09
(2 630.50 - 3 118.40) 
1 859.87 
(1 626.45 - 2 126.86) 0.001
Intervention (2008) N=217 N=217
Median No. days in hospital (min - max) 7 (1 - 46) 7 (1 - 160) 0.81
Cost per day in hospital (R) (GMean (range))
284.14
(250.94 - 321.73)
371.92
(327.49 - 422.36) 0.008 
Cost per admission (R) (GMean (range))
2 097.47 
(1 855.79 - 2 370.69)
2 429.25 
(2 105.60 - 2 802.65) 0.003 
GMean = geometric mean.
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admission in this group increasing from R1 859.87 to R2 429.25 – an 
increase of 23%. The mean cost per day admitted in this group also 
increased, from R363.54 to R371.92 – an increase of 2.2%.
In summary, the intervention appears to have resulted in a reduction 
in costs in the group as a whole and in the cost per admission in this 
group. In contrast, the control group incurred no major change in 
costs from the pre-intervention to the intervention periods. The 
baseline costs in the two groups appear to be significantly different, 
cost per day in hospital being R442.90 versus R363.54 (p=0.09) 
and mean cost per admission being R2 864.09 versus R1 859.87 
(p=0.001), the higher costs being incurred in the intervention group 
at baseline. This difference is largely attributed to the intervention 
group admitting a significantly larger number of patients (260 
compared with 203) over the specified period, as well as the patients 
in the intervention group spending an extra night in hospital (6.46 
compared with 5.76, p=0.05).
The ANOVA results (not shown) indicated that there was an 
interaction between group and time (p=0.001), indicating that the 
intervention was better than the control over time. The intervention 
and control groups were further compared with respect to the ratios 
of their geometric means.
The 95% confidence interval revealed that for the control group 
the costs during period 2 (intervention period) could be between 
14% lower and 22% higher than those of period 1 (pre-intervention 
period). However, in the intervention group, the costs during period 
2 (intervention period) could be between 25% and 45% lower than 
those of period 1 (pre-intervention period).
Discussion
We hypothesised that providing clinicians with the cost of the 
laboratory tests that they were in the process of ordering would 
enable them to question the need and appropriateness of the test 
without compromising patient care, and in so doing result in reduced 
laboratory test expenditure. In this study, providing cost information 
was associated with a significant change in physician test-ordering 
behaviour. After adjusting for the annual 2.5% increase in laboratory 
test costs between the control period in 2007 and the intervention 
period in 2008, the test costs dropped by 27 - 36 % in the intervention 
group compared with the control group.
This study has reaffirmed important measures in cost reduction 
strategies, two of which should be emphasised: (i) doctors have a 
limited knowledge and understanding of diagnostic costs; and (ii) 
more focus is required in their education in this regard, and these 
costs should be made accessible to them.14 We found that physicians 
ordered fewer diagnostic tests after being given this information 
during the test-ordering process. Unfortunately, this study did 
not measure any outcome data between the groups, viz. mortality, 
morbidity, length of hospital stay, intensive care unit admission and 
patient satisfaction. It would have been interesting to see what impact 
the cost reductions might have had on these outcome measures, 
especially if patient outcomes were similar between the groups.
Our findings are in agreement with those of Goddard and Austin, 
who confirmed that the implementation of a blood investigation 
order chart resulted in a net reduction of 33% in the number of 
blood investigations ordered.15 Another simple measure of weekly 
announcement of monetary cost charged to surgical inpatients for 
laboratory services, over a 11-week period, led to a 27% saving for 
the hospital.16
Clinicians have a responsibility to ensure that all tests requested 
on behalf of the patients in their care are appropriate. Laboratory and 
radiological testing costs represent a significant proportion of the 
expenditure of most health care providers, including state teaching 
hospitals. While the costs of individual tests may be relatively fixed, a 
computer order entry system provides an opportunity for controlling 
these costs. The literature supports the use of such a system, in 
the context of appropriate education, funding and policy setting.17 
Unfortunately, in state teaching hospitals these systems are rare and 
not sustainable; hence the need for an immediate, practical and 
sustainable system of curbing the escalating laboratory costs.
We conclude by asserting that the mere displaying of charges for 
diagnostic tests on the laboratory request form may significantly 
reduce both the number and cost of tests ordered, and that doing so 
brings about considerable in-hospital cost savings, at least in tertiary 
care settings. Whether this is applicable to community hospital 
settings needs further investigation.
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